Anatomical and functional remodeling of left ventricle in patients with primary aldosteronism and concomitant albuminuria.

BACKGROUND

Primary aldosteronism (PA) is the leading cause of secondary hypertension globally and is associated with adverse cardiovascular outcomes. However, the cardiac impact of concomitant albuminuria remains unknown.

OBJECTIVE

To compare anatomical and functional remodeling of left ventricle (LV) in PA patients with or without albuminuria.

DESIGN

Prospective cohort study.

METHODS

The cohort was separated into two arms according to the presence or absence of albuminuria (>30 mg/g of morning spot urine). Propensity score matching with age, sex, systolic blood pressure, and diabetes mellitus was performed. Multivariate analysis was conducted with adjustments for age, sex, body mass index, systolic blood pressure, duration of hypertension, smoking, diabetes mellitus, number of antihypertensive agents, and aldosterone level. A local-linear model with bandwidth of 2.07 was used to study correlations.

RESULTS

A total of 519 individuals with PA were enrolled in the study, of whom 152 had albuminuria. After matching, the albuminuria group had a higher creatinine level, at baseline. With regard to LV remodeling, albuminuria was independently associated with a significantly higher interventricular septum (1.22 > 1.17 cm,  = 0.030), LV posterior wall thickness (1.16 > 1.10 cm,  = 0.011), LV mass index (125 > 116 g/m,  = 0.023), and medial E/e' ratio (13.61 > 12.30,  = 0.032), and a lower medial early diastolic peak velocity (5.70 < 6.36 cm/s,  = 0.016). Multivariate analysis further revealed that albuminuria was an independent risk factor for elevated LV mass index ( < 0.001) and medial E/e' ratio ( = 0.010). Non-parametric kernel regression also demonstrated that the level of albuminuria was positively correlated with LV mass index. The remodeling of LV mass and diastolic function under the presence of albuminuria distinctly improved after PA treatment.

CONCLUSION

The presence of concomitant albuminuria in patients with PA was associated with pronounced LV hypertrophy and compromised LV diastolic function. These alterations were reversible after treatment for PA.

PLAIN LANGUAGE SUMMARY

Primary aldosteronism and albuminuria has been, respectively, demonstrated to bring about left ventricular remodeling, but the aggregative effect was unknown. We constructed a prospective single-center cohort study in Taiwan. We proposed the presence of concomitant albuminuria was associated with left ventricular hypertrophy and compromised diastolic function. Intriguingly, management of primary aldosteronism was able to restore these alterations. Our study delineated the cardiorenal crosstalk in the setting of secondary hypertension and the role of albuminuria for left ventricular remodeling. Future interrogations toward the underlying pathophysiology as well as therapeutics will facilitate the improvement of holistic care for such population.